Stocks and Investing
Stocks and Investing
Mon, May 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Reiterated (BCYC) at Strong Buy and Held Target at $55 on, May 3rd, 2024
Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $55 on, May 3rd, 2024.
Swayampakula has made no other calls on BCYC in the last 4 months.
There are 2 other peers that have a rating on BCYC. Out of the 2 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Swayampakula
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $43 on, Wednesday, April 10th, 2024
- Bill Maughan of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $60 on, Wednesday, February 21st, 2024
Contributing Sources